- Home
- L vs BNTX Comparison
L vs BNTX Comparison
Compare L & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | L | BNTX |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8B | 24.2B |
| IPO Year | 1998 | 2019 |
Fundamental Metrics
Financial Performance| Metric | L | BNTX |
|---|---|---|
| Price | $106.81 | $95.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $133.46 |
| AVG Volume (30 Days) | 528.9K | ★ 795.6K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 24.34 | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $18,454,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.37 |
| P/E Ratio | $13.14 | ★ N/A |
| Revenue Growth | ★ 5.39 | N/A |
| 52 Week Low | $86.59 | $79.81 |
| 52 Week High | $114.90 | $124.00 |
Technical Indicators
Market Signals| Indicator | L | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 43.93 |
| Support Level | $101.95 | $91.74 |
| Resistance Level | $108.12 | $112.77 |
| Average True Range (ATR) | 2.31 | 3.62 |
| MACD | -0.56 | -0.90 |
| Stochastic Oscillator | 34.09 | 2.52 |
Price Performance
Historical ComparisonAbout L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.